Literature DB >> 23041129

Drug release modification by interpolymer interaction between countercharged types of Eudragit® RL 30D and FS 30D in double-layer films.

Rouslan I Moustafine1, Andrey V Bodrov, Vera A Kemenova, Patrick Rombaut, Guy Van den Mooter.   

Abstract

Interpolymer interactions between the countercharged methacrylate copolymers Eudragit(®) RL 30D (polycation) and Eudragit(®) FS 30D (polyanion), were investigated in conditions mimicking the gastrointestinal environment. The formation of inter-macromolecular ionic bonds between Eudragit(®) RL 30D and Eudragit(®) FS 30D was investigated using FT-IR spectroscopy and modulated DSC. The FT-IR spectra of the tested polymeric matrices are characterized by visible changes in the observed IR region indicating the interaction between chains of two oppositely charged copolymers. A new band at 1570 cm(-1) appeared which was assigned to the absorption of the carboxylate groups that form the ionic bonds with the quaternary ammonium groups. Moreover, while increasing the pH values from pH 5.8 to 7.4, a decrease of the intensity of the band at 960 cm(-1) (quaternary ammonium group vibration) was observed. All binary mixtures were characterized by the presence of only one and narrow Tg, pointing to sample homogeneity, because of the compatibility of components. As a result of electrostatic interaction between the copolymer chains during swelling, the resulting Tg is decreased significantly and was dependent on the quantity of copolymers present in the structure of polycomplexes formed. Overall, the interaction between countercharged copolymers during passage in gastrointestinal tract can strongly modify the release profile of the model drug diclofenac sodium.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041129     DOI: 10.1016/j.ijpharm.2012.09.044

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  An In Vitro Thrombolysis Study Using a Mixture of Fast-Acting and Slower Release Microspheres.

Authors:  Hoai X Nguyen; Edgar A O'Rear
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

2.  Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.

Authors:  Robert Wulff; Claudia S Leopold
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

3.  Synthesis of Zinc Oxide Eudragit FS30D Nanohybrids: Structure, Characterization, and Their Application as an Intestinal Drug Delivery System.

Authors:  Fan Luo; Mingjie Wang; Liting Huang; Ziqian Wu; Wenxiong Wang; Ayesha Zafar; Yunbo Tian; Murtaza Hasan; Xugang Shu
Journal:  ACS Omega       Date:  2020-05-13

4.  A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds.

Authors:  Armin Mooranian; Nassim Zamani; Momir Mikov; Svetlana Goločorbin-Kon; Goran Stojanovic; Frank Arfuso; Bozica Kovacevic; Hani Al-Salami
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.